参考文献/References:
[1] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global,regional,and national incidence,prevalence,and years lived with disability for 354 diseases and injuries for 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2018,392(10159):1789-1858.
[2] Virani SS,Alonso A,Aparicio HJ,et al. Heart disease and stroke statistics—2021 update:a report from the American Heart Association[J]. Circulation,2021,143(8):e254-e743.
[3] Chen S,Huang Z,Liang Y,et al. Five-year mortality of heart failure with preserved,mildly reduced,and reduced ejection fraction in a 4880 Chinese cohort[J]. ESC Heart Fail,2022,9(4):2336-2347.
[4] Ghani U,Farooq O,Aziz S,et al. The spectrum of heart failure management[J]. Cureus,2023,15(6):e40587.
[5] Raphael C,Briscoe C,Davies J,et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure[J]. Heart,2007,93(4):476-482.
[6] Guyatt GH,Sullivan MJ,Thompson PJ,et al. The 6-minute walk:a new measure of exercise capacity in patients with chronic heart failure[J]. Can Med Assoc J,1985,132(8):919-923.
[7] Kotta PA,Nambi V,Bozkurt B. Biomarkers for heart failure prediction and prevention[J]. J Cardiovasc Dev Dis,2023,10(12):488.
[8] Saunders JT,Nambi V,de Lemos JA,et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease,heart failure,and mortality in the Atherosclerosis Risk in Communities Study[J]. Circulation,2011,123(13):1367-1376.
[9] Mirsky I,Parmley WW. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart[J]. Circ Res,1973,33(2):233-243.
[10] Collier P,Phelan D,Klein A. A test in context:myocardial strain measured by speckle-tracking echocardiography[J]. J Am Coll Cardiol,2017,69(8):1043-1056.
[11] Pedrizzetti G,Claus P,Kilner PJ,et al. Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use[J]. J Cardiovasc Magn Reson,2016,18(1):51.
[12] Thiele H,Paetsch I,Schnackenburg B,et al. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession[J]. J Cardiovasc Magn Reson,2002,4(3):327-339.
[13] Claus P,Omar AMS,Pedrizzetti G,et al. Tissue tracking technology for assessing cardiac mechanics:principles,normal values,and clinical applications[J]. JACC Cardiovasc Imaging,2015,8(12):1444-1460.
[14] Schuster A,Kutty S,Padiyath A,et al. Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress[J]. J Cardiovasc Magn Reson,2011,13(1):58.
[15] Kowallick JT,Lamata P,Hussain ST,et al. Quantification of left ventricular torsion and diastolic recoil using cardiovascular magnetic resonance myocardial feature tracking[J]. PLoS One,2014,9(10):e109164.
[16] Li G,Zhang Z,Gao Y,et al. Age- and sex-specific reference values of biventricular strain and strain rate derived from a large cohort of healthy Chinese adults:a cardiovascular magnetic resonance feature tracking study[J]. J Cardiovasc Magn Reson,2022,24(1):63.
[17] Sardana M,Konda P,Hashmath Z,et al. Usefulness of left ventricular strain by cardiac magnetic resonance feature-tracking to predict cardiovascular events in patients with and without heart failure[J]. Am J Cardiol,2019,123(8):1301-1308.
[18] Shah AM,Claggett B,Sweitzer NK,et al. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone[J]. Circulation,2015,132(5):402-414.
[19] Kammerlander AA,Kraiger JA,Nitsche C,et al. Global Longitudinal strain by CMR?feature?tracking is associated with?outcome in HFPEF[J]. JACC Cardiovasc Imaging,2019,12(8 Pt 1):1585-1587.
[20] Freed BH,Daruwalla V,Cheng JY,et al. Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction:importance of left atrial strain[J]. Circ Cardiovasc Imaging,2016,9(3):10.
[21] Lange T,Schuster A. Quantification of myocardial deformation applying CMR-feature-tracking—All about the left ventricle?[J]. Curr Heart Fail Rep,2021,18(4):225-239.
[22] Tanacli R,Hashemi D,Lapinskas T,et al. Range variability in CMR feature tracking multilayer strain across different stages of heart failure[J]. Sci Rep,2019,9(1):16478.
[23] Ito H,Ishida M,Makino W,et al. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction:correlation of global longitudinal strain with invasive diastolic functional indices[J]. J Cardiovasc Magn Reson,2020,22(1):42.
[24] Tanacli R,Hashemi D,Neye M,et al. Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction[J]. ESC Heart Fail,2020,7(5):3240-3245.
[25] Seno A,Antiochos P,Lichtenfeld H,et al. Prognostic value of T1 mapping and feature tracking by cardiac magnetic resonance in patients with signs and symptoms suspecting heart failure and no clinical evidence of coronary artery disease[J]. J Am Heart Assoc,2022,11(2):e020981.
[26] Li YY,Craft J,Cheng YJ,et al. Left ventricle wall motion analysis with real-time MRI feature tracking in heart failure patients:a pilot study[J]. Diagnostics (Basel),2022,12(12):2946.
[27] Rolf A,Keller T,Wolter JS,et al. Right ventricular strain by magnetic resonance feature tracking is largely afterload-dependent and does not reflect contractility:validation by combined volumetry and invasive pressure tracings[J]. Diagnostics (Basel),2022,12(12):3183.
[28] Bredy C,Ministeri M,Kempny A,et al. New York Heart Association (NYHA) classification in adults with congenital heart disease:relation to objective measures of exercise and outcome[J]. Eur Heart J Qual Care Clin Outcomes,2018,4(1):51-58.
[29] Chacon-Portillo MA,Acharya T,Janardhanan R. Imaging in heart failure with preserved ejection fraction:insights into echocardiography and cardiac magnetic resonance imaging[J]. Rev Cardiovasc Med,2021,22(1):11-24.
[30] He J,Yang W,Jiang Y et al. Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance:From clinical uses to emerging techniques[J]. Trends Cardiovasc Med,2023,33(3):141-147.
[31] Dobrovie M,Barreiro-Pérez M,Curione D,et al. Inter-vendor reproducibility and accuracy of segmental left ventricular strain measurements using CMR feature tracking[J]. Eur Radiol,2019,29(12):6846-6857.
[32] He J,Sirajuddin A,Li S,et al. Heart failure with preserved ejection fraction in hypertension patients:a myocardial MR strain Study[J]. J Magn Reson Imaging,2021,53(2):527-539.
[33] Al Musa T,Uddin A,Swoboda PP et al. Myocardial strain and symptom severity in severe aortic stenosis:insights from cardiovascular magnetic resonance[J]. Quant Imaging Med Surg,2017,7(1):38-47.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(5):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(5):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(5):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(5):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(5):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]